GFA 116
consists of a calix(4)arene scaffold attached to four cyclic GKGK peptides; inhibits tumorigenesis and angiogenesis in mice; inhibits VEGF binding to Flk-1; structure in first source
Also Known As:
GFA-116; GFA116
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Blaskovich, Michelle A:
1 article
(05/2004)
|
2. | Brem, Steven:
1 article
(05/2004)
|
3. | Choi, Kihang:
1 article
(05/2004)
|
4. | Coppola, Domenico:
1 article
(05/2004)
|
5. | Delarue, Frederic:
1 article
(05/2004)
|
6. | Hamilton, Andrew D:
1 article
(05/2004)
|
7. | Jain, Rishi K:
1 article
(05/2004)
|
8. | Lin, Qing:
1 article
(05/2004)
|
9. | Mullan, Michael:
1 article
(05/2004)
|
10. | Paris, Daniel:
1 article
(05/2004)
|
Related Diseases
Related Drugs and Biologics